Literature DB >> 8842751

Monoclonal antibodies against human chondrocytes.

J Bujia1, M Sittinger, H Sudhoff, A Fisseler-Eckhoff, G R Burmester, E Kastenbauer, C Hammer.   

Abstract

Cell-specific antigens are mainly found in cells or membrane surfaces rather than in the surrounding matrix. However, until now it was not possible to produce antibodies specific for cellular structures of chondrocytes. In 1989, Lance (Immunol. Lett. 21:63-73; 1989) first established specific monoclonal antibodies for human articular chondrocytes tested only by immunofluorescence. Studies describing the specificity of these five antibodies (HUMC 1-5) and their relevance for immunohistological analysis of cartilage tissue were not available until now. Therefore, the aim of the following study was to investigate the distribution of HUMC 1, 2, 3, 4, and 5 in mesenchymal cells in vivo and in vitro immunohistochemically. Further investigations concentrate on the localization of chondrocyte specific antigens using immunoelectron microscopy. Immunohistological studies showed positive immunostainings with all five antibodies in human chondrocytes in vivo and in vitro. A cross-reaction with human fibroblasts and osteoblasts for the antibodies HUMC 2 and HUMC 5 was observed. Furthermore, a parallel loss of immunoreactivity for HUMC 1, HUMC 3, and HUMC 4 was observed in cultured chondrocytes indicating that the specific antigens vanish during differentiation observed in vitro. Subsequent immunoblot analysis employing collagens as antigens did not show any reactivity. Using immunoelectron microscopy, gold particle labeling was observed in intracytoplasmatic vesicles of isolated chondrocytes. Our results indicate that HUMC 1, HUMC 3, and HUMC 4 are specific for cartilage cells and might be suitable for immunohistological analysis of different cartilage tissues and pathologically altered chondrocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842751     DOI: 10.1007/bf02722963

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  21 in total

1.  Class II antigen induction in cartilage.

Authors:  J Bujia; E Wilmes; C Hammer; G R Burmester; S Alsalameh
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

2.  Immunological reactivity towards chondrocytes in rat and man: relevance to autoimmune arthritis.

Authors:  E M Lance
Journal:  Immunol Lett       Date:  1989-04       Impact factor: 3.685

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Studies in the transplantation of allogeneic cartilage across known histocompatibility barriers.

Authors:  J Stjernswärd
Journal:  Bibl Haematol       Date:  1965

Review 5.  The collagens: an overview and update.

Authors:  E J Miller; S Gay
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 6.  Cartilage cell differentiation: review.

Authors:  K von der Mark; G Conrad
Journal:  Clin Orthop Relat Res       Date:  1979 Mar-Apr       Impact factor: 4.176

7.  Environmental regulation of type X collagen production by cultures of limb mesenchyme, mesectoderm, and sternal chondrocytes.

Authors:  M Solursh; K L Jensen; R S Reiter; T M Schmid; T F Linsenmayer
Journal:  Dev Biol       Date:  1986-09       Impact factor: 3.582

8.  Antigen presenting cell function of class II positive human nasal chondrocytes.

Authors:  J Bujía; S Alsalameh; M Sittinger; C Hammer; E Wilmes; G Burmester
Journal:  Acta Otolaryngol       Date:  1994-01       Impact factor: 1.494

9.  Class II histocompatibility antigen-mediated immunologic function of normal articular chondrocytes.

Authors:  M L Tiku; S Liu; C W Weaver; M Teodorescu; J L Skosey
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

10.  Cellular heterogeneity in cultured human chondrocytes identified by antibodies specific for alpha 2(XI) collagen chains.

Authors:  B Swoboda; R Holmdahl; H Stöss; K von der Mark
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.